This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Anaxis Pharma Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Jean-Marc Daniel Garnier
Introduction
Jean-Marc Daniel Garnier is an accomplished inventor based in Parkville, Australia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on sulphonamide compounds. His research focuses on developing compounds that can be utilized in medical treatments.
Latest Patents
Jean-Marc Garnier holds a patent for sulphonamide compounds, which relates to compounds of formula (I) and includes salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs, and/or prodrugs thereof. This invention is particularly noteworthy for its application in treating necroptosis and inhibiting MLKL.
Career Highlights
Garnier is associated with Anaxis Pharma Pty Ltd, where he continues to advance his research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, especially in the treatment of various diseases.
Collaborations
Throughout his career, Jean-Marc Garnier has collaborated with notable colleagues, including Carole Annie Schuster-Klein and Christophe Poitevin. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jean-Marc Daniel Garnier's contributions to the field of pharmaceuticals through his patent on sulphonamide compounds exemplify the importance of innovation in medical science. His work continues to pave the way for advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile